Publication

Byline

Location

Clinical Trial: Priming Using Contrast Training Exercise

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754669) titled 'Priming Using Contrast Training Exercise' on Aug. 04. Brief Summary: This study investigat... और पढ़ें


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... और पढ़ें


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... और पढ़ें


Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... और पढ़ें


Clinical Trial: A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis Suppurativa

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756346) titled 'A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis Suppurati... और पढ़ें


Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... और पढ़ें


Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... और पढ़ें


Clinical Trial: Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756138) titled 'Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex' on July 24. Brief Summary: T... और पढ़ें


Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxe... और पढ़ें


Clinical Trial: PENTAGON: MS-Related Disability Worsening and Thalamic Volume Loss

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07753928) titled 'PENTAGON: MS-Related Disability Worsening and Thalamic Volume Loss' on Aug. 03. Brief Summ... और पढ़ें